The pharmacology of aldose reductase inhibitors - PubMed (original) (raw)

Review

The pharmacology of aldose reductase inhibitors

P F Kador et al. Annu Rev Pharmacol Toxicol. 1985.

No abstract available

PubMed Disclaimer

Similar articles

• Aldose reductase inhibitors and diabetic complications.
  Raskin P, Rosenstock J. Raskin P, et al. Am J Med. 1987 Aug;83(2):298-306. doi: 10.1016/0002-9343(87)90702-9. Am J Med. 1987. PMID: 3113248 Review. No abstract available.
• [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
  Hotta N, Sakamoto N. Hotta N, et al. Nihon Rinsho. 1987 Dec;45(12):3010-27. Nihon Rinsho. 1987. PMID: 3128677 Review. Japanese. No abstract available.
• Aldose reductase inhibitors and the complications of diabetes mellitus.
  Tomlinson DR. Tomlinson DR. Diabet Med. 1993 Apr;10(3):214-30. doi: 10.1111/j.1464-5491.1993.tb00049.x. Diabet Med. 1993. PMID: 8485953 Review. No abstract available.
• Aldose reductase inhibitors.
  Kirchain WR, Rendell MS. Kirchain WR, et al. Pharmacotherapy. 1990;10(5):326-36. Pharmacotherapy. 1990. PMID: 2122421 Review.
• Aldose reductase in the diabetic eye. XLIII Edward Jackson memorial lecture.
  Kinoshita JH. Kinoshita JH. Am J Ophthalmol. 1986 Dec 15;102(6):685-92. doi: 10.1016/0002-9394(86)90394-6. Am J Ophthalmol. 1986. PMID: 3098107

Cited by

• Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights.
  Hamdi A, Yaseen M, Ewes WA, Bhat MA, Ziedan NI, El-Shafey HW, Mohamed AAB, Elnagar MR, Haikal A, Othman DIA, Elgazar AA, Abusabaa AHA, Abdelrahman KS, Soltan OM, Elbadawi MM. Hamdi A, et al. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2231170. doi: 10.1080/14756366.2023.2231170. J Enzyme Inhib Med Chem. 2023. PMID: 37470409 Free PMC article.
• Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine.
  Balogh M, Janjic JM, Shepherd AJ. Balogh M, et al. Antioxid Redox Signal. 2022 Jan;36(1-3):122-143. doi: 10.1089/ars.2021.0123. Antioxid Redox Signal. 2022. PMID: 34416821 Free PMC article.
• Synthesis and α-Glucosidase Inhibition Activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2_H_-benzo[e][1,2]thiazin-2-yl]-_N_-arylacetamides: An In Silico and Biochemical Approach.
  Saddique FA, Aslam S, Ahmad M, Ashfaq UA, Muddassar M, Sultan S, Taj S, Hussain M, Sung Lee D, Zaki MEA. Saddique FA, et al. Molecules. 2021 May 20;26(10):3043. doi: 10.3390/molecules26103043. Molecules. 2021. PMID: 34065194 Free PMC article.
• The Protective Effects of Flavonoids in Cataract Formation through the Activation of Nrf2 and the Inhibition of MMP-9.
  Hilliard A, Mendonca P, Russell TD, Soliman KFA. Hilliard A, et al. Nutrients. 2020 Nov 27;12(12):3651. doi: 10.3390/nu12123651. Nutrients. 2020. PMID: 33261005 Free PMC article. Review.
• Vitamin K1 prevents diabetic cataract by inhibiting lens aldose reductase 2 (ALR2) activity.
  Thiagarajan R, Varsha MKNS, Srinivasan V, Ravichandran R, Saraboji K. Thiagarajan R, et al. Sci Rep. 2019 Oct 11;9(1):14684. doi: 10.1038/s41598-019-51059-2. Sci Rep. 2019. PMID: 31604989 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ingenta plc

• Other Literature Sources

  • The Lens - Patent Citations